{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:42:59Z","timestamp":1792798979982,"version":"4.5.0"},"reference-count":205,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Dept. of Biotechnology, Govt. of India","doi-asserted-by":"publisher","award":["DBT-843-BIO"],"award-info":[{"award-number":["DBT-843-BIO"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Dept. of Biotechnology, Govt. of India","doi-asserted-by":"publisher","award":["SER-1058-BIO"],"award-info":[{"award-number":["SER-1058-BIO"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board, Govt. of India","doi-asserted-by":"publisher","award":["DBT-843-BIO"],"award-info":[{"award-number":["DBT-843-BIO"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board, Govt. of India","doi-asserted-by":"publisher","award":["SER-1058-BIO"],"award-info":[{"award-number":["SER-1058-BIO"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Mucormycosis is an invasive fungal infection caused by fungi belonging to order Mucorales. Recently, with the increase in COVID-19 infections, mucormycosis infections have become a matter of concern globally, because of the high morbidity and mortality rates associated with them. Due to the association of mucormycosis with COVID-19 disease, it has been termed COVID-19-associated mucormycosis (CAM). In the present review, we focus on mucormycosis incidence, pathophysiology, risk factors, immune dysfunction, interactions of Mucorales with endothelial cells, and the possible role of iron in Mucorales growth. We review the limitations associated with current diagnostic procedures and the requirement for more specific, cost-effective, convenient, and sensitive assays, such as PCR-based assays and monoclonal antibody-based assays for the effective diagnosis of mucormycosis. We discuss the current treatment options involving antifungal drug therapies, adjunctive therapy, surgical treatment, and their limitations. We also review the importance of nutraceuticals-based therapy for the prevention as well as treatment of mucormycosis. Our review also highlights the need to explore the potential of novel immunotherapeutics, which include antibody-based therapy, cytokine-based therapy, and combination\/synergistic antifungal therapy, as treatment options for mucormycosis. In summary, this review provides a complete overview of COVID-19-associated mucormycosis, addressing the current research gaps and future developments required in the field.<\/jats:p>","DOI":"10.3390\/vaccines10081266","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T09:47:06Z","timestamp":1660124826000},"page":"1266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-7614","authenticated-orcid":false,"given":"Pankaj","family":"Chandley","sequence":"first","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9675-2474","authenticated-orcid":false,"given":"Priyanka","family":"Subba","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-3132","authenticated-orcid":false,"given":"Soma","family":"Rohatgi","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rodrigues, M.L., and Nosanchuk, J.D. (2020). Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0007964"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/S2666-5247(21)00148-8","article-title":"Mucormycosis: Time to address this deadly fungal infection","volume":"2","author":"Stone","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11046-017-0153-5","article-title":"Rhizopus homothallicus Causing Invasive Infections: Series of Three Cases from a Single Centre in North India","volume":"182","author":"Kokkayil","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00433-18","DOI":"10.1128\/JCM.00433-18","article-title":"Emerging Rhizopus microsporus Infections in India","volume":"56","author":"Pandey","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/mmy\/myz031","article-title":"An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India","volume":"58","author":"Prakash","year":"2020","journal-title":"Med. Mycol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/mmy\/myz081","article-title":"Mucormycosis due to Apophysomyces species complex- 25 years\u2019 experience at a tertiary care hospital in southern India","volume":"58","author":"Pamidimukkala","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chander, J., Kaur, M., Singla, N., Punia, R.P.S., Singhal, S.K., Attri, A.K., Alastruey- Izquierdo, A., Stchigel, A.M., Cano-Lira, J.F., and Guarro, J. (2018). Mucormycosis: Battle with the deadly enemy over a five-year period in India. J. Fungi, 4.","DOI":"10.3390\/jof4020046"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/JCM.02326-10","article-title":"Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India","volume":"49","author":"Hemashettar","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/JCM.06611-11","article-title":"Evidence implicating Thamnostylum lucknowense as an etiological agent of rhino-orbital mucormycosis","volume":"50","author":"Xess","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Richardson, M.D., and Rautemaa-Richardson, R. (2020). Biotic Environments Supporting the Persistence of Clinically Relevant Mucormycetes. J. Fungi, 6.","DOI":"10.3390\/jof6010004"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2009.02972.x","article-title":"The ecology of the Zygomycetes and impact on environmental exposure","volume":"15","author":"Richardson","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/21501203.2018.1551251","article-title":"Antifungal-resistant Mucorales in different indoor environments","volume":"10","author":"Caetano","year":"2018","journal-title":"Mycology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/mmy\/myx051","article-title":"Occurrence and species distribution of pathogenic Mucorales in unselected soil samples from France","volume":"56","author":"Mousavi","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/mmy\/myw014","article-title":"The environmental source of emerging Apophysomyces variabilis infection in India","volume":"54","author":"Prakash","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijid.2020.05.110","article-title":"Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?","volume":"97","author":"Edeas","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5858\/2001-125-0375-HFOZ","article-title":"Histologic Features of Zygomycosis Emphasis on Perineural Invasion and Fungal Morphology","volume":"125","author":"Frater","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J. Laryngol. Otol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0035-1562896","article-title":"Mucormycosis: New Developments into a Persistently Devastating Infection","volume":"36","author":"Danion","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in Human Disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Baldin, C., and Ibrahim, A.S. (2017). Molecular mechanisms of mucormycosis\u2014The bitter and the sweet. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006408"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"111643","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: An opportunistic pathogen during COVID-19","volume":"201","author":"Mahalaxmi","year":"2021","journal-title":"Environ. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/mjdrdypu.mjdrdypu_641_21","article-title":"Mucormycosis: An addendum to India\u2019s COVID-19 woes","volume":"15","author":"Roy","year":"2022","journal-title":"Med. J. DY Patil Vidyapeeth"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101007","DOI":"10.1016\/j.mycmed.2020.101007","article-title":"Mucormycosis treatment: Recommendations, latest advances, and perspectives","volume":"30","author":"Brunet","year":"2020","journal-title":"J. Mycol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: Pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a Viral Land: A Tale of Two Pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_33","first-page":"71","article-title":"Invasive fungal infections in patients with COVID-19: A review on pathogenesis, epidemiology, clinical features, treatment, and outcomes","volume":"44","author":"Chiurlo","year":"2021","journal-title":"New Microbiol."},{"key":"ref_34","first-page":"363","article-title":"Emergence of Mucormycosis: A Therapeutic Challenge for COVID-19 in Pakistan","volume":"6","author":"Kanwar","year":"2021","journal-title":"Saudi J. Pathol. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM and ISHAM. ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus Disease (COVID-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: We should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J. Mycol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijid.2021.09.057","article-title":"Five probable factors responsible for the COVID-associated mucormycosis outbreak in India","volume":"112","author":"Ravindra","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_42","first-page":"S0255","article-title":"COVID-19 Associated Mucormycosis: Ramping up our services during crisis","volume":"1","author":"Xess","year":"2022","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"John, T.M., Jacob, C.N., and Kontoyiannis, D.P. (2021). When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J. Fungi, 7.","DOI":"10.3390\/jof7040298"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Prakash, H., and Chakrabarti, A. (2021). Epidemiology of Mucormycosis in India. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030523"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00405-022-07282-1","article-title":"Mucormycosis in COVID-19 pandemic: Study at tertiary hospital in India","volume":"279","author":"Chavan","year":"2022","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_46","first-page":"e13163","article-title":"A Case of Fatal Rhino-Orbital Mucormycosis Associated with New Onset Diabetic Ketoacidosis and COVID-19","volume":"13","year":"2021","journal-title":"Cureus"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mmcr.2021.03.006","article-title":"Pulmonary aspergillosis and mucormycosis in a patient with COVID-19","volume":"32","author":"Johnson","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zurl, C., Hoenigl, M., Schulz, E., Hatzl, S., Gorkiewicz, G., Krause, R., Eller, P., and Prattes, J. (2021). Autopsy Proven Pulmonary Mucormycosis due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy. J. Fungi, 7.","DOI":"10.3390\/jof7020088"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2100510","DOI":"10.2807\/1560-7917.ES.2021.26.23.2100510","article-title":"Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021","volume":"26","author":"Buil","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel","year":"2021","journal-title":"Mycoses"},{"key":"ref_51","first-page":"1029","article-title":"Fulminant mucormycosis complicating coronavirus disease","volume":"11","author":"Arastou","year":"2021","journal-title":"Int Forum Allergy Rhinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"NP11","DOI":"10.1177\/11206721211009450","article-title":"Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report","volume":"32","author":"Veisi","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"103911","DOI":"10.1016\/j.amsu.2022.103911","article-title":"Mucormycosis, One Month after Recovery from COVID-19: A Case Report","volume":"78","author":"Alian","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/IOP.0000000000001889","article-title":"Case Reports Acute Invasive Rhino-Orbital Mucormycosis in a Patient with COVID-19-Associated Acute Respiratory Distress Syndrome","volume":"37","author":"Mekonnen","year":"2021","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral Mucormycosis and COVID-19 Pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J. Med. Cases"},{"key":"ref_56","first-page":"1","article-title":"Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19","volume":"Mar 23","author":"Dallalzadeh","year":"2021","journal-title":"Orbit"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"106522","DOI":"10.1016\/j.ijscr.2021.106522","article-title":"The diversity and outcome of post-covid mucormycosis: A case report","volume":"88","author":"Mobarak","year":"2021","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.5578\/mb.20219719","article-title":"Two Case of Rhino-Orbito-Cerebral Mucormicosis Developed after COVID-19 Infection","volume":"55","author":"Canpolat","year":"2021","journal-title":"Mikrobiyol. Bul."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12348-021-00272-0","article-title":"Acute bilateral blindness in a young Covid-19 patient with rhino-orbito- cerebral mucormycosis","volume":"11","author":"Malek","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_60","first-page":"703","article-title":"Rhinocerebral mucormycosis in a covid-19 patient from nepal: A case report","volume":"59","author":"Gupta","year":"2021","journal-title":"J. Nepal Med. Assoc."},{"key":"ref_61","first-page":"76","article-title":"Acute Rhino-orbital-cerebral Mucormycosis in a Patient with COVID\u201319","volume":"38","author":"Naqvi","year":"2022","journal-title":"Pak. J. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: A new phenomenon in the developing world\u2009?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/hcab176","article-title":"COVID-19-associated rhino-orbital mucormycosis: A single-centre experience of 10 cases","volume":"114","author":"Arjun","year":"2021","journal-title":"QJM Int. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids\u2014An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J. Maxillofac. Oral Surg."},{"key":"ref_65","first-page":"e10726","article-title":"Rhino-Orbital Mucormycosis Associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e244232","DOI":"10.1136\/bcr-2021-244232","article-title":"Orbital mucormycosis in a COVID-19 patient","volume":"14","author":"Baskar","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A challenging complication following SARS-CoV- 2 infection: A case of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2021","journal-title":"Infection"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"105957","DOI":"10.1016\/j.ijscr.2021.105957","article-title":"Sino-orbital mucormycosis in a COVID-19 patient: A case report","volume":"82","author":"Maini","year":"2021","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4103\/ijo.IJO_1053_21","article-title":"Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features","volume":"69","author":"Rao","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_71","first-page":"1","article-title":"Paranasal Mucormycosis in COVID-19 Patient","volume":"22","author":"Saldanha","year":"2021","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S1473-3099(21)00582-X","article-title":"Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis","volume":"21","author":"Arora","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"100099","DOI":"10.1016\/j.clinpr.2021.100099","article-title":"Mandibular mucormycosis following SARS-CoV-2 infection\u2014A case report and review of literature","volume":"12","author":"Ambereen","year":"2021","journal-title":"Clin. Infect. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101203","DOI":"10.1016\/j.mycmed.2021.101203","article-title":"First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus","volume":"31","author":"Diwakar","year":"2021","journal-title":"J. Med. Mycol."},{"key":"ref_75","first-page":"101511","article-title":"Massive hemoptysis causing mortality in a post COVID-19 infected Asian male patient: Presenting as pulmonary mucormycosis, pulmonary tuberculosis and later sino-nasal mucormycosis","volume":"34","author":"Rana","year":"2021","journal-title":"Respir. Med. Case Rep."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hussain, S., Riad, A., Singh, A., Klugarov\u00e1, J., Antony, B., Banna, H., and Klugar, M. (2021). Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis. J. Fungi, 7.","DOI":"10.3390\/jof7110985"},{"key":"ref_77","first-page":"504","article-title":"Mucormycosis in COVID-19: A systematic review of literature","volume":"29","author":"Nagalli","year":"2021","journal-title":"Infez. Med."},{"key":"ref_78","first-page":"31","article-title":"COVID-19-associated mucormycosis of head-and-neck region: A systematic review","volume":"8","author":"Kamat","year":"2022","journal-title":"J. Clin. Transl. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and mucormycosis superinfection: The perfect storm","volume":"49","author":"Alhumaid","year":"2021","journal-title":"Infection"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: Experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/myc.12897","article-title":"Mucormycosis\u2014A clinicoepidemiological review of cases over 10 years","volume":"62","author":"Manesh","year":"2019","journal-title":"Mycoses"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/0886022X.2016.1268537","article-title":"Invasive fungal infections in renal transplant patients: A single center study","volume":"39","author":"Patel","year":"2017","journal-title":"Ren. Fail."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5005\/jp-journals-10071-23387","article-title":"Mucormycosis in a tertiary care center in south india: A 4-year experience","volume":"24","author":"Priya","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Skiada, A., Pavleas, I., and Drogari-Apiranthitou, M. (2020). Epidemiology and diagnosis of mucormycosis: An update. J. Fungi, 6.","DOI":"10.3390\/jof6040265"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5582\/ddt.2017.01060","article-title":"Breakthrough mucormycosis after voriconazole use in a case of invasive fungal rhinosinusitis due to Curvularia lunata","volume":"11","author":"Gupta","year":"2017","journal-title":"Drug Discov. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MPH.0b013e3182331bc7","article-title":"Oral Voriconazole Versus Intravenous Low Dose Amphotericin B for Primary Antifungal Prophylaxis in Pediatric Acute Leukemia Induction: A Prospective, Randomized, Clinical Study","volume":"33","author":"Mandhaniya","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acsinfecdis.1c00371","article-title":"Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis","volume":"7","author":"Singh","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus disease 2019 treatment: A review of early and emerging options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"102169","DOI":"10.1016\/j.dsx.2021.06.006","article-title":"Absence of Case of Mucormycosis (March 2020\u2013May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit","volume":"15","author":"Mulakavalupil","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2991\/jegh.k.210521.001","article-title":"Clinical Features and Outcome of Low and High Corticosteroids in Admitted COVID-19 Patients","volume":"11","author":"AlBahrani","year":"2021","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_93","first-page":"20499361211027065","article-title":"COVID-19 associated mucormycosis: The urgent need to reconsider the indiscriminate use of immunosuppressive drugs","volume":"8","author":"Sah","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1152\/ajpendo.00480.2020","article-title":"COVID-19 Endocrinopathy with Hindsight from SARS","volume":"320","author":"Kothandaraman","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_96","first-page":"2","article-title":"Maxillofacial Infections in Covid-19 Era\u2014Actuality or the Unforeseen: 2 Case Reports","volume":"2","author":"Krishna","year":"2021","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/tid.13652","article-title":"Mucormycosis associated with COVID-19 in two kidney transplant patients","volume":"23","author":"Arana","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_98","first-page":"e22973","article-title":"Epidemiology of Mucormycosis Cases during the Second Wave of COVID-19 in a Tertiary Care Institute in Western Rajasthan, India","volume":"14","author":"Kumar","year":"2022","journal-title":"Cureus"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"108291","DOI":"10.1016\/j.diabres.2020.108291","article-title":"High prevalence of COVID-19- associated diabetic ketoacidosis in UK secondary care","volume":"166","author":"Goldman","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17843286.2020.1780390","article-title":"Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: Case report and review of the literature","volume":"77","author":"Oriot","year":"2020","journal-title":"Acta Clin. Belg. Int. J. Clin. Lab. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jmv.26227","article-title":"Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19","volume":"93","author":"Smith","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.dsx.2020.08.015","article-title":"Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Xue, T., Li, Q., Zhang, Q., Lin, W., Wen, J., Li, L., and Chen, G. (2020). Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: A retrospective study in a single center. MedRxiv.","DOI":"10.1101\/2020.03.31.20048579"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/bmt.2016.306","article-title":"Hyperglycemia as a possible risk factor for mold infections\u2014The potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Fuji","year":"2017","journal-title":"Bone Marrow Transpl."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2021.12.039","article-title":"Risk factors for Coronavirus disease-associated mucormycosis","volume":"84","author":"Arora","year":"2022","journal-title":"J. Infect."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/14787210.2021.1960822","article-title":"The rise of mucormycosis in COVID-19 patients in India","volume":"20","author":"Bhatia","year":"2022","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhin.2022.01.016","article-title":"Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India\u2014A multi-centre study","volume":"122","author":"Biswal","year":"2022","journal-title":"J. Hosp. Infect."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"03001","DOI":"10.7189\/jogh.12-03001","article-title":"Mucormycosis and COVID-19: Double trouble for India?","volume":"12","author":"Yasmin","year":"2022","journal-title":"J. Glob. Health"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e00473-22","DOI":"10.1128\/mbio.00473-22","article-title":"Are Unique Regional Factors the Missing Link in India\u2019s COVID-19-Associated Mucormycosis Crisis?","volume":"13","author":"Skaria","year":"2022","journal-title":"mBio"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/myc.13365","article-title":"Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study","volume":"64","author":"Muthu","year":"2021","journal-title":"Mycoses"},{"key":"ref_112","first-page":"e22528","article-title":"Role of Zinc and Clinicopathological Factors for COVID-19-Associated Mucormycosis (CAM) in a Rural Hospital of Central India: A Case-Control Study","volume":"14","author":"Kumar","year":"2022","journal-title":"Cureus"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Bilgic, A., Kodjikian, L., Sudhalkar, A., Dwivedi, S., Vasavada, V., Shah, A., Dziadzko, M., and Mathis, T. (2022). Risk Factors for COVID-19 Associated Mucormycosis: The Ophthalmologist\u2019s Perspective. J. Fungi, 8.","DOI":"10.3390\/jof8030271"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4269\/ajtmh.21-0608","article-title":"Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic","volume":"105","author":"Ghazi","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/iai.38.3.1123-1129.1982","article-title":"Generation of Chemotactic Factors by Rhizopus oryzae in the Presence and Absence of Serum: Relationship to Hyphal Damage Mediated by Human Neutrophils and Effects of Hyperglycemia and Ketoacidosis","volume":"38","author":"Chinnt","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mmcr.2020.05.008","article-title":"A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well- controlled diabetic patient","volume":"29","author":"Hoang","year":"2020","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1113\/EP089400","article-title":"Mechanical ventilation in COVID-19: A physiological perspective","volume":"107","author":"Cronin","year":"2022","journal-title":"Exp. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/j.bjoms.2021.10.018","article-title":"Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: Probing the triggering factors","volume":"60","author":"Arakeri","year":"2022","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: A case report","volume":"53","author":"Ribeiro","year":"2020","journal-title":"Clin. Endosc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14336\/AD.2021.0811","article-title":"The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India","volume":"13","author":"Chakrabarti","year":"2022","journal-title":"Aging Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mib.2017.10.010","article-title":"The mucormycete\u2013host interface","volume":"40","author":"Ibrahim","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12663-021-01604-2","article-title":"Current Understanding in the Pathophysiology of SARS-CoV-2- Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review","volume":"20","author":"Jose","year":"2021","journal-title":"J. Maxillofac. Oral Surg."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.2020.1623","article-title":"Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China","volume":"323","author":"Chang","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_125","first-page":"e23016","article-title":"Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience from a Tertiary Care Center in South India","volume":"14","author":"Kandasamy","year":"2022","journal-title":"Cureus"},{"key":"ref_126","first-page":"76","article-title":"Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components","volume":"70","author":"Bouchara","year":"1996","journal-title":"Eur. J. Cell. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","article-title":"GRP78: A cell\u2019s response to stress","volume":"226","author":"Ibrahim","year":"2019","journal-title":"Life Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1177932220965505","DOI":"10.1177\/1177932220965505","article-title":"Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules","volume":"14","author":"Allam","year":"2020","journal-title":"Bioinform. Biol. Insights"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.54055","article-title":"Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19","volume":"17","author":"Fu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","article-title":"COVID-19 spike-host cell receptor GRP78 binding site prediction","volume":"80","author":"Ibrahim","year":"2020","journal-title":"J. Infect."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/CMR.12.3.394","article-title":"Acquisition, Transport, and Storage of Iron by Pathogenic Fungi","volume":"12","author":"Howard","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3174\/ajnr.A6588","article-title":"Cerebrovascular Disease in COVID-19","volume":"41","author":"Goldberg","year":"2020","journal-title":"Am. J. Neuroradiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1039\/C4IB00025K","article-title":"Diagnostic morphology: Biophysical indicators for iron-driven inflammatory diseases","volume":"6","author":"Pretorius","year":"2014","journal-title":"Integr. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"102573","DOI":"10.1016\/j.autrev.2020.102573","article-title":"COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?","volume":"19","author":"Colafrancesco","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12026-020-09145-5","article-title":"COVID-19 as part of the hyperferritinemic syndromes: The role of iron depletion therapy","volume":"68","author":"Perricone","year":"2020","journal-title":"Immunol. Res."},{"key":"ref_139","first-page":"e20569","article-title":"Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients","volume":"13","author":"Bhadania","year":"2021","journal-title":"Cureus"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"100005","DOI":"10.1016\/j.hsr.2021.100005","article-title":"Mucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic","volume":"1","author":"Fathima","year":"2021","journal-title":"Health Sci. Rev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review","volume":"10","author":"Cavezzi","year":"2020","journal-title":"Clin. Pract."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13062-020-00275-2","article-title":"COVID-19 and iron dysregulation: Distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein","volume":"15","author":"Ehsani","year":"2020","journal-title":"Biol. Direct"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/21505594.2015.1009732","article-title":"Iron starvation induces apoptosis in rhizopus oryzae in vitro","volume":"6","author":"Shirazi","year":"2015","journal-title":"Virulence"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.271.5255.1552","article-title":"A permease-oxidase complex involved in high-affinity iron uptake in yeast","volume":"271","author":"Stearman","year":"1996","journal-title":"Science"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11033-021-06862-4","article-title":"COVID-19-associated-mucormycosis: Possible role of free iron uptake and immunosuppression","volume":"49","author":"Tabassum","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis","volume":"77","author":"Ibrahim","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref_149","first-page":"11","article-title":"Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease","volume":"70","author":"Rao","year":"2022","journal-title":"J. Assoc. Physicians India"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: Guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1469-0691.2009.02999.x","article-title":"Zygomycosis: Conventional laboratory diagnosis","volume":"15","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"684.e11","DOI":"10.1016\/j.cmi.2015.03.019","article-title":"Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis","volume":"21","author":"Jung","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<100::AID-PATH100>3.0.CO;2-O","article-title":"and T.O.E. et al. the use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies","volume":"181","author":"Jensen","year":"1997","journal-title":"J. Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Resch","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"594.e1","DOI":"10.1016\/j.cmi.2015.01.017","article-title":"Molecular identification of Mucorales in human tissues: Contribution of PCR electrospray-ionization mass spectrometry","volume":"21","author":"Alanio","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1469-0691.2009.02983.x","article-title":"Molecular tools for identification of zygomycetes and the diagnosis of zygomycosis","volume":"15","author":"Dannaoui","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/myc.12234","article-title":"Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India","volume":"57","author":"Chowdhary","year":"2014","journal-title":"Mycoses"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.01222-09","article-title":"Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis","volume":"54","author":"Lewis","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Sahu, R.K., Salem-Bekhit, M.M., Bhattacharjee, B., Almoshari, Y., Ikbal, A.M.A., Alshamrani, M., Bharali, A., Salawi, A., Widyowati, R., and Alshammari, A. (2021). Mucormycosis in indian covid-19 patients: Insight into its patho-genesis, clinical manifestation, and management strategies. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091079"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases","volume":"42","author":"Hare","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1179\/joc.2009.21.3.272","article-title":"In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries","volume":"21","author":"Verweij","year":"2009","journal-title":"J. Chemother."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00492-08","article-title":"Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro","volume":"52","author":"Perkhofer","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/jac\/dkz102","article-title":"In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales","volume":"74","author":"Schwarz","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/jac\/dkab233","article-title":"Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis","volume":"76","author":"Gebremariam","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"John","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The deferasirox-AmBisome therapy for mucormycosis (Defeat Mucor) study: A randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw090","article-title":"Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae","volume":"214","author":"Bellanger","year":"2016","journal-title":"Proc. J. Infect. Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ijbiomac.2021.07.156","article-title":"Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis\u2014A comprehensive review","volume":"187","author":"Singh","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1139\/W09-096","article-title":"Anti-inflammatory drugs selectively target sporangium development in Mucor","volume":"55","author":"Leeuw","year":"2009","journal-title":"Can. J. Microbiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"103465","DOI":"10.1016\/j.amjoto.2022.103465","article-title":"Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center","volume":"43","author":"Mrig","year":"2022","journal-title":"Am. J. Otolaryngol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Pokharkar, O., Lakshmanan, H., Zyryanov, G., and Tsurkan, M. (2022). In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis. Mar. Drugs, 20.","DOI":"10.3390\/md20030215"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"O336","DOI":"10.1111\/1469-0691.12408","article-title":"Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival","volume":"20","author":"Vironneau","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00405-020-06441-6","article-title":"The microscope drape method to reduce aerosolisation during endoscopic sinus and skull base surgery in the COVID era. How i do it","volume":"278","author":"Tsagkovits","year":"2021","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Saluja, G., Bhari, A., Pushker, N., Agrawal, S., Meel, R., Thakar, A., Xess, I., Khandelwal, A., Narwal, A., and Bajaj, M.S. (2022). Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective. Med. J. Armed Forces India, Epub ahead of print.","DOI":"10.1016\/j.mjafi.2022.01.009"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13337-020-00598-8","article-title":"Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor","volume":"31","author":"Maurya","year":"2020","journal-title":"Virus Dis."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"109048","DOI":"10.1016\/j.abb.2021.109048","article-title":"Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae","volume":"712","author":"Prajapati","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1076\/phbi.41.5.392.15941","article-title":"Antifungal activity of the essential oils of nine Zingiberaceae species","volume":"41","author":"Jantan","year":"2003","journal-title":"Pharm. Biol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"119201","DOI":"10.1016\/j.lfs.2021.119201","article-title":"COVID-19, cytokines, inflammation, and spices: How are they related?","volume":"284","author":"Kunnumakkara","year":"2021","journal-title":"Life Sci."},{"key":"ref_185","first-page":"1","article-title":"The double trouble: COVID-19 associated mucormycosis a focused review and future perspectives","volume":"16","author":"Agnihotri","year":"2021","journal-title":"Glob. J. Med. Pharm. Biomed. Update"},{"key":"ref_186","first-page":"1","article-title":"Neem and Turmeric in the management of Covid Associated Mucormycosis (CAM) derived through network pharmacology","volume":"Mar 7","author":"Datta","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_187","unstructured":"(2022, July 15). Guideline for Management of Mucormycosis in COVID-19 Patients, Available online: https:\/\/dghs.gov.in\/WriteReadData\/News\/202105171119301555988MucormycosismanagementinCovid-19.pdf."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijid.2022.04.009","article-title":"Posaconazole or Isavuconazole as sole or predominant antifungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series","volume":"120","author":"Soman","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_189","first-page":"267","article-title":"Invasive fungal infection in the immunosuppressed host","volume":"11","author":"Salit","year":"1975","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1398-9995.1995.tb05054.x","article-title":"Studies on shared antigenic\/allergenic components among fungi","volume":"50","author":"Verma","year":"1995","journal-title":"Allergy"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1099\/00221287-139-7-1557","article-title":"The production and partial characterization of a monoclonal IgG antibody specific for moulds belonging to the order Mucorales","volume":"139","author":"Bos","year":"1993","journal-title":"J. Gen. Microbiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e00094-18","DOI":"10.1128\/mSphere.00094-18","article-title":"Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target","volume":"3","author":"Hubbard","year":"2018","journal-title":"mSphere"},{"key":"ref_193","first-page":"255","article-title":"Significance of MUC5B antibody in differential diagnosis between Aspergillus species and Mucorales of fungal sinusitis","volume":"37","author":"Piao","year":"2008","journal-title":"Chin. J. Pathol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0733-8635(05)70437-X","article-title":"Fungal disease in the immunocompromised host","volume":"15","author":"Myskowski","year":"1997","journal-title":"Dermatol. Clin."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/myc.12431","article-title":"Natural killer cell- mediated damage of clinical isolates of mucormycetes","volume":"59","author":"Schmidt","year":"2016","journal-title":"Mycoses"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00520-005-0910-8","article-title":"Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies","volume":"14","author":"Grigull","year":"2006","journal-title":"Support. Care Cancer"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Jenks, J.D., Rawlings, S.A., Garcia-Vidal, C., Koehler, P., Mercier, T., Prattes, J., Lass-Fl\u00f6rl, C., Martin-Gomez, M.T., Buchheidt, D., and Pagano, L. (2019). Immune parameters for diagnosis and treatment monitoring in invasive mold infection. J. Fungi, 5.","DOI":"10.3390\/jof5040116"},{"key":"ref_198","first-page":"15","article-title":"IFN-\u03b3 mediated signaling improves fungal clearance in experimental pulmonary mucormycosis","volume":"187","author":"Finato","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"eaaw1327","DOI":"10.1126\/sciadv.aaw1327","article-title":"Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis","volume":"5","author":"Gebremariam","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e01087-20","DOI":"10.1128\/mBio.01087-20","article-title":"GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis","volume":"11","author":"Alqarihi","year":"2020","journal-title":"mBio"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.riam.2020.07.002","article-title":"Identification of Mucor circinelloides antigens recognized by sera from immunocompromised infected mice","volume":"37","author":"Areitio","year":"2020","journal-title":"Rev. Iberoam Micol."},{"key":"ref_202","unstructured":"Ibrahim, A.S., Spellberg, B.J., Fu, Y., and Edwards, J.E. (2013). Vaccine Compositions and Methods for Treatment of Mucormycosis and Other Fungal Diseases. (8,444,985 B2), U.S. Patent."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"863234","DOI":"10.3389\/fimmu.2022.863234","article-title":"Immunoinformatic Design of a Multivalent Peptide Vaccine Against Mucormycosis: Targeting FTR1 Protein of Major Causative Fungi","volume":"13","author":"Araf","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Pritam, M., Singh, G., Kumar, R., and Singh, S.P. (2022). Screening of potential antigens from whole proteome and development of multi-epitope vaccine against Rhizopus delemar using immunoinformatics approaches. J. Biomol. Struct. Dyn., 1\u201328.","DOI":"10.1080\/07391102.2022.2028676"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Naveed, M., Ali, U., Karobari, M.I., Ahmed, N., Mohamed, R.N., Abullais, S.S., Kader, M.A., Marya, A., Messina, P., and Scardina, G.A. (2022). A Vaccine Construction against COVID-19-Associated Mucormycosis Contrived with Immunoinformatics-Based Scavenging of Potential Mucoralean Epitopes. Vaccines, 10.","DOI":"10.3390\/vaccines10050664"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:05:06Z","timestamp":1760141106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":205,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["vaccines10081266"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10081266","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]}}}